*These authors contributed equally to this work Keywords: GFRα-RET complex, risk of developing MTC, Polymorphisms, haplotypes Copyright (C) 2005 by The Endocrine Society Context. Medullary thyroid carcinoma is a characteristic tumour occurring in individuals with multiple endocrine neoplasia type 2, who carry germ line mutations in RET. However, most MTC occur in individuals without family history. Objectives. To explore the possibility that susceptibility in these cases results from low penetrance alleles of RET, its co-receptors and ligands. Design. We carried out an association study in 135 sporadic MTC (sMTC) and 533 controls from the UK-population. Results and conclusions. We analyzed 33 polymorphisms in all 9 genes involved in the GFR...
Medullary thyroid carcinoma (MTC) originates from neural crest-derived parafollicular C cells and ac...
The object of this work was to compare the frequency of three polymorphic changes in the RET proto-o...
Introduction: Thyroid cancer represents more than 90% of endocrine tumors and its incidence, predomi...
Background: Sporadic medullary thyroid carcinoma (sMTC) is an uncommon neoplasia arising from the ca...
BACKGROUND: Highly discrepant data about the different distribution of RET germline single nucleotid...
Background: Highly discrepant data about the different distribution of RET germline single nucleotid...
RET single nucleotide polymorphisms (SNPs) have been implicated in the pathogenesis and progression ...
Medullary thyroid carcinoma (MTC) is a rare tumour arising from neural crest-derived parafollicular ...
Germline RET variants are responsible for approximately 25% of medullary thyroid carcinoma (MTC) cas...
Abstract: Medullary thyroid carcinoma (MTC) is a rare calcitonin producing neuroendocrine tumour tha...
Many single nucleotide polymorphisms (SNPs) of the RET gene have been described both in the general ...
The genetic mechanisms underlying the multistep process of medullary thyroid carcinoma (MTC) develop...
Medullary thyroid carcinoma (MTC) represents 3-5% of thyroid cancers. 75% is sporadic and 25% is the...
Objective: Mutations in the RET proto-oncogene are found in about one third of sporadic medullary th...
RET mutations play an important role in the development of human neuroendocrine tumors. The prevalen...
Medullary thyroid carcinoma (MTC) originates from neural crest-derived parafollicular C cells and ac...
The object of this work was to compare the frequency of three polymorphic changes in the RET proto-o...
Introduction: Thyroid cancer represents more than 90% of endocrine tumors and its incidence, predomi...
Background: Sporadic medullary thyroid carcinoma (sMTC) is an uncommon neoplasia arising from the ca...
BACKGROUND: Highly discrepant data about the different distribution of RET germline single nucleotid...
Background: Highly discrepant data about the different distribution of RET germline single nucleotid...
RET single nucleotide polymorphisms (SNPs) have been implicated in the pathogenesis and progression ...
Medullary thyroid carcinoma (MTC) is a rare tumour arising from neural crest-derived parafollicular ...
Germline RET variants are responsible for approximately 25% of medullary thyroid carcinoma (MTC) cas...
Abstract: Medullary thyroid carcinoma (MTC) is a rare calcitonin producing neuroendocrine tumour tha...
Many single nucleotide polymorphisms (SNPs) of the RET gene have been described both in the general ...
The genetic mechanisms underlying the multistep process of medullary thyroid carcinoma (MTC) develop...
Medullary thyroid carcinoma (MTC) represents 3-5% of thyroid cancers. 75% is sporadic and 25% is the...
Objective: Mutations in the RET proto-oncogene are found in about one third of sporadic medullary th...
RET mutations play an important role in the development of human neuroendocrine tumors. The prevalen...
Medullary thyroid carcinoma (MTC) originates from neural crest-derived parafollicular C cells and ac...
The object of this work was to compare the frequency of three polymorphic changes in the RET proto-o...
Introduction: Thyroid cancer represents more than 90% of endocrine tumors and its incidence, predomi...